Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut J F Salzer

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Pneumologie (Stuttgart, Germany)|November 21, 2025
[Summary of the update to the S3 guideline: Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Cardiovascular Research|October 5, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational studyDavid Pereyra, Stefan Heber, Waltraud C Schrottmaier, et al.
Infection|August 8, 2024
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Pneumologie (Stuttgart, Germany)|April 1, 2025
[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Pathogens & Immunity|February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture ConversionMaja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
Frontiers in Cellular and Infection Microbiology|February 10, 2022
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External ValidationStefan Heber, David Pereyra, Waltraud C Schrottmaier, et al.
The European Respiratory Journal|March 3, 2022
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statementEva Van Braeckel, Iain Page, Jesper Rømhild Davidsen, et al.
The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.
Emerging Infectious Diseases|July 18, 2018
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained SettingsDavid W Denning, Iain D Page, Jeremiah Chakaya, et al.
Wiener Klinische Wochenschrift|April 22, 2022
Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) : Updated statement of the Austrian Society of Pneumology (ASP)Horst Olschewski, Ernst Eber, Brigitte Bucher, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Pneumologie (Stuttgart, Germany)|November 21, 2025
[Summary of the update to the S3 guideline: Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Cardiovascular Research|October 5, 2021
Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational studyDavid Pereyra, Stefan Heber, Waltraud C Schrottmaier, et al.
Infection|August 8, 2024
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Pneumologie (Stuttgart, Germany)|April 1, 2025
[Epidemiology, diagnosis and treatment of adult patients with nosocomial pneumonia]Jessica Rademacher, Santiago Ewig, Béatrice Grabein, et al.
Pathogens & Immunity|February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture ConversionMaja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
Frontiers in Cellular and Infection Microbiology|February 10, 2022
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External ValidationStefan Heber, David Pereyra, Waltraud C Schrottmaier, et al.
The European Respiratory Journal|March 3, 2022
Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statementEva Van Braeckel, Iain Page, Jesper Rømhild Davidsen, et al.
The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.
Emerging Infectious Diseases|July 18, 2018
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained SettingsDavid W Denning, Iain D Page, Jeremiah Chakaya, et al.
Wiener Klinische Wochenschrift|April 22, 2022
Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022) : Updated statement of the Austrian Society of Pneumology (ASP)Horst Olschewski, Ernst Eber, Brigitte Bucher, et al.
Pageof 10